✉news ScienceBiology first seen 10 h ago, last 59 min ago, peak #8
CellsBin Raises Series A Led By 108 BioCapital
Original: CellsBin Raises Series A Led By 108 BioCapital To Advance Rare-Cell Intelligence Platform
Biotech company CellsBin has announced a Series A funding round led by 108 BioCapital, with proceeds earmarked for advancing its rare-cell intelligence platform. The platform focuses on detecting and analyzing rare cells, a capability relevant to research and diagnostics in areas like oncology and rare disease. The funding signals continued investor interest in specialized cell-analysis technologies.
Why now: Fresh Series A funding for a specialized biotech platform draws attention from investors and the life sciences community.
Rank over time, top of the chart is #1. 8 snapshots from 10 h ago to 59 min ago.
Evidence
- CellsBin Raises Series A Led By 108 BioCapital To Advance Rare-Cell Intelligence Platform · Pulse 2.0
API: https://socialmediatrends-api.osmike.com/v1/trends/736237